pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Communication 52

Communication 52

PharmaShots

MAY 12, 2023

Sanofi Reports P-IIIb Trial (HARMONIE) Results of Nirsevimab for the Prevention of Hospitalizations due to RSV-Related LRTD Date: May 12, 2023 | Tags: Sanofi, Nirsevimab, RSV-Related LRTD, Clinical Trial, P-IIIb, HARMONIE Trial G1 Therapeutics Presents Preliminary Results from P-II Trial of Trilaciclib for Triple-Negative Breast Cancer at ESMO 2023 (..)

FDA 40

FDA Chemotherapy Immunization Hospitals 40

European Pharmaceutical Review

DECEMBER 9, 2022

According to a new market report by ResearchAndMarkets, the global oligonucleotide synthesis market is projected to reach $16.7 Agilent Technologies, Inc. (US). Tag Copenhagen A/S (Denmark). The research projected a compound annual growth rate (CAGR) of 16.8 percent from $7.7 billion in 2022. Alnylam Pharmaceuticals, Inc. (US).

Compounding 84

Compounding 84

Viseven

MAY 24, 2023

This April was truly intense for Viseven in terms of events: weeks after visiting New York, our team went on to Reuters Pharma 2023 in Barcelona, while Korea Bio & Pharma meeting took place in Seoul the same weekend. For that matter, the attendees could choose between three stages and a more quiet lunch zone for personal communication.

Customer Service 52

Customer Service Communication 52

Pharmaceutical Technology

NOVEMBER 9, 2022

million price tag. While experts interviewed by Pharmaceutical Technology found the cost-effectiveness estimates valid, the durability of gene therapies in haemophilia remains unclear, particularly in the case of Roctavian, which has faced similar queries from regulatory authorities. appeared first on Pharmaceutical Technology.

FDA 111

FDA 111

European Pharmaceutical Review

AUGUST 24, 2022

Early dose-limiting toxicities have prohibited the expansion of ADCs into larger and more complex tumour indications, dampening the initial hopes of a new “magic bullet” in the fight against cancer. Tubulis’ second technology platform is called Tub?tag generation products from fully delivering on their initial promise.

Compounding 80

Compounding Pharmaceutical Companies Pharmaceutical Companies 80

Pharmaceutical Technology

MAY 1, 2023

CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

52

52

pharmaphorum

SEPTEMBER 15, 2020

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.

Communication 127

Communication Documentation Labelling Vaccines 127

European Pharmaceutical Review

MARCH 1, 2023

In a recent study, Massachusetts Institute of Technology (MIT) researchers developed a new purification method to cut the costs of manufacturing protein drugs. The authors explained that these are commonly used for tagging proteins for study or attaching protein drugs to drug-delivering nanoparticles.

Vaccines 92

Vaccines 92

ISPE

DECEMBER 1, 2022

Winner of the ISPE Italy Affiliate’s Women in Pharma® Graziella Molinari Award in 2021, thanks to her project for the inclusion of #smart tags in a site production in order to improve not only efficiency, but also quality and compliance in a 4.0 trillion dollars in global turnover. Micaela Prati. perspective. .

98

98

Pharmaceutical Technology

DECEMBER 5, 2022

Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total. In most EU and Commonwealth countries, including the UK, New Zealand and Australia, cannabinoids are legal for medical use.

Controlled Substances 98

Controlled Substances Compounding Immunization 98

pharmaphorum

APRIL 20, 2021

NICE’s final appraisal document for Kesimpta will be followed by technology appraisal guidance (TAG) that will pave the way for NHS prescribing in England and Wales. There are around 130,000 people with MS in the UK, with 7,000 new diagnoses a year.

Hospitals 111

Hospitals Documentation 111

Pharmaceutical Technology

JANUARY 17, 2023

Despite its high price tag, bimagrumab’s unique features set it apart from currently marketed therapies. The post Versanis’ bimagrumab, first-in-class obesity therapy, enters Phase IIb of development appeared first on Pharmaceutical Technology.

Hospitals 52

Hospitals 52

Pharmaceutical Technology

FEBRUARY 22, 2023

Both drugs come with a high price tag. In its past statements shared with other outlets, Amgen stated that patents need to give researchers wide protection to incentivise new inventions. Enablement as the crux of the case Amgen could win at the Supreme Court, says Shahrokh Falati, professor of law at the New York Law School.

FDA 104

FDA 104

Pharmaceutical Technology

JUNE 29, 2022

For example, while orphan drug designations have more than doubled in the last decade compared to the previous one, only 16% of therapies with orphan tags have managed to gain FDA approval in some indications. GlobalData is the parent company of Pharmaceutical Technology. Have orphan drug designations increased in recent years?

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

Pharmaceutical Technology

MAY 15, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Immunization Vaccines 52

pharmaphorum

NOVEMBER 24, 2022

Johnson & Johnson’s Spravato therapy for treatment-resistant depression (TRD) hasn’t made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate its take-up.

Labelling 52

Labelling Hospitals 52

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time.

Health and Personal Care Stores 40

Health and Personal Care Stores Medical Records Hospitals 40

pharmaphorum

DECEMBER 23, 2022

In the last few years, the first generation of cell therapies has offered a powerful new way of treating blood cancers, with CAR-T technology reprogramming patients’ immune system to fight cancer. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Immunization 52

Immunization Hospitals Vaccines 52

Pharmaceutical Technology

APRIL 13, 2023

Although the findings in the report are only preliminary, they shed light at the considerations behind the high price tags of gene therapies. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity.

FDA 59

FDA 59

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. In an exclusive interview with Pharmaceutical Technology , Bruce Levine, PhD, talks about the past, present, and future of CAR-T therapies and what challenges lie ahead.

FDA 59

FDA Immunization 59

Pharmaceutical Technology

JULY 14, 2022

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). “The Go-to-market strategies. The choice of where to launch an orphan drug is an important and difficult decision.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

Viseven

NOVEMBER 30, 2022

From AI-based drug discovery to running virtual cohorts for clinical trials or doing continuous manufacturing instead of batch manufacturing, from launching a project effectively to doing real-world tickets, there is technology penetration all along the value chain. And then all the technology will be applied to it.

52

52

Viseven

JUNE 23, 2022

The faster digitalization goes worldwide, the more pharma companies find out about new tools and approaches for digital self-promotion. Digitalization brought new challenges to any industry related to online activities and social influence. Pharma and the specialties of pharma’s marketing appeared to be under influence as well.

Communication 52

Communication 52

pharmaphorum

NOVEMBER 27, 2022

Fully integrated and automated ingredient to consumer batch tracking using barcoding, RFID tagging, or IoT temperature logging and timestamping significantly reduces the chance of these mix-ups, providing complete traceability records from ingredient manufacturer to patient, and ensures the safety of the product.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

PharmaShots

MARCH 9, 2023

Other Affiliations: Presently, Aida serves as an Executive Board Member for the International Science Reserve in The New York Academy of Sciences Board of Governors. Award & Nominations: The Healthcare Technology Report named Karen as the second-best Women Leader in Medical Devices at the beginning of 2021.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

Viseven

FEBRUARY 6, 2023

Personalization at scale Personalization isn’t a new healthcare marketing trend for digital marketers in the pharma and healthcare industries. Omnichannel engagement technology enables healthcare marketers to provide better customer experience — evenly across all channels and avoid pointless repetition of the same content.

Communication 75

Communication 75

Pharmaceutical Technology

JUNE 21, 2023

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. Despite the limited market, the price tags of haemophilia make it potentially lucrative. Haemophilia B is a rare condition.

FDA 98

FDA 98

pharmaphorum

JUNE 15, 2021

Can the biopharma industry step up again to shatter industry orthodoxy and create new pathways for innovation, access, and affordability? New Science is more important than ever, driving more growth than predicted, revitalising operations and revealing new opportunities to innovate. New Science is more important than ever.

Vaccines 90

Vaccines 90

Viseven

SEPTEMBER 14, 2023

We highlight the need for competent personnel, ethical supplier relationships, and robust technology to navigate challenges and adopt strategies for efficient procurement, incorporating innovative technologies like IoT sensors, blockchain, and data analytics. Data analytics There is a reason data is called the new gold.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmacy Procurement 52

Pharmaceutical Technology

JANUARY 27, 2023

On January 18, Sanofi launched a new warranty program for its rare blood disorder drug Cablivi (caplacizumab), which tackles value-based agreements in a slightly different way. Sanofi’s new warranty program offers institutions a refund for the cost of six doses of a treatment if it is not effective.

Documentation 52

Documentation Immunization Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

FEBRUARY 16, 2021

In this first draft guidance NICE raised a series of issues with Zynteglo, which bluebird has already agreed to supply at a confidential discount from its hefty price tag, which is around €1.57 million in Europe. NICE said that data came from a small sample of patients and is using its standard discount rate of 3.5%

85

85

European Pharmaceutical Review

NOVEMBER 10, 2022

A new wave of medicines has emerged in recent years to supplement the well-established small and large molecule platforms that have historically dominated the market. While there is a significant market opportunity in this sector, advanced analytical methods are required, and many technologies cannot provide the resolution needed.

Labelling 94

Labelling Compounding 94

European Pharmaceutical Review

JULY 11, 2022

8 vaccine technology, also has the potential to reduce the costs and supply chain complications associated with production of most vaccines. For example, the new vaccine eliminates the need for cold storage and specialist skills currently concentrated in few nations, increasing its accessibility. . The innovative protein ?“glue”

Vaccines 91

Vaccines Immunization 91

pharmaphorum

SEPTEMBER 30, 2022

Component management is fairly new to the regulatory market, with pharmaceutical firms moving from traditional document management systems to more dynamic component content management systems. Companies increasingly recognize the need to adopt technologies such as artificial intelligence (AI) to assist with this paradigm shift.

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

OCTOBER 10, 2022

Using sophisticated assignment rules and virtual tagging, each line item inside the unified bill can be assigned to its business role, feature, team, and product. Finout's new suite of business intelligence dashboards provides teams with relevant business insights along with traditional SRE dashboarding data.

Communication 52

Communication 52

pharmaphorum

OCTOBER 4, 2022

The new stage of the Moonshot has been established on the contribution and the role that US citizens can play in this effort. The biospecimens and associated health data will then be made available to cancer scientists, potentially offering the opportunity to discover new treatments.

Documentation 105

Documentation Data Entry HIPAA Insurance 105